Figure 2.

Changes in (A) the pre-ejection period/ejection time (PEP/ET) ratio, (B) serum N-terminal pro B-type natriuretic peptide (NT-proBNP), and (C) brachial-ankle pulse wave velocity (baPWV) during the study period among the groups classified according the serum uric acid (UA) levels measured at the first (2009) and second (2012) examinations. Data are the mean±SD. High-UA, serum UA >7 mg/dL in both 2009 and 2012; Low-UA, serum UA ≤7 mg/dL in both 2009 and 2012; and Indeterminate-UA, serum UA ≤7 mg/dL in 1 examination (2009 or 2012) and >7 mg/dL in the other examination (2009 or 2012).